β-blockers reduce the incidence of clinical restenosis: prospective study of 4840 patients undergoing percutaneous coronary revascularization
- 31 May 2003
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 145 (5) , 875-881
- https://doi.org/10.1016/s0002-8703(02)94726-5
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Carvedilol for Prevention of Restenosis After Directional Coronary AtherectomyCirculation, 2000
- Early decrease in minimal luminal diameter after successful percutaneous transluminal coronary angioplasty predicts late restenosisThe American Journal of Cardiology, 1993
- Migration of smooth muscle and endothelial cells. Critical events in restenosis.Circulation, 1992
- The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplastyJournal of the American College of Cardiology, 1991
- Role of beta-adrenergic blockers after percutaneous transluminal coronary angioplastyThe American Journal of Cardiology, 1990
- Angioscopic observation of the coronary luminal changes induced by percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1989
- Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months.Circulation, 1988
- Restenosis After Successful Percutaneous Transluminal Coronary Angioplasty: Serial Angiographic Follow-Up of 229 PatientsJournal of the American College of Cardiology, 1988
- Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA registry of the national heart, lung, and blood instituteThe American Journal of Cardiology, 1984
- Myocardial Infarction and Mortality in the Coronary Artery Surgery Study (CASS) Randomized TrialNew England Journal of Medicine, 1984